Alpha-Defensins Research for Viral Infections
An evidence-based overview of research examining Alpha-Defensins in the context of viral infections. This page synthesizes findings from peer-reviewed literature.
Research Summary
In vitro studies demonstrate alpha-defensins can inactivate various enveloped viruses including HIV-1, HSV, and influenza. HNP-1-3 appear to interfere with viral entry and fusion. Clinical significance remains unclear as therapeutic delivery presents challenges.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Viral Infections
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Alpha-Defensins may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.